{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:58:47Z","timestamp":1784692727603,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972086"],"award-info":[{"award-number":["81972086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672196"],"award-info":[{"award-number":["81672196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["18YF1413600"],"award-info":[{"award-number":["18YF1413600"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802177"],"award-info":[{"award-number":["81802177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.intimp.2021.107458","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T16:44:43Z","timestamp":1613925883000},"page":"107458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["p300\/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss"],"prefix":"10.1016","volume":"94","author":[{"given":"Shicheng","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-5605","authenticated-orcid":false,"given":"Zhuocheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin'en","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107458_b0005","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1084\/jem.20181554","article-title":"Kr\u00fcppel-like factor 3 inhibition by mutated lncRNA Reg1cp results in human high bone mass syndrome","volume":"216","author":"Yang","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2021.107458_b0010","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/molecules23123086","article-title":"l-Quebrachitol Promotes the Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells: Involvement of the BMP-2\/Runx2\/MAPK\/Wnt\/\u03b2-Catenin Signaling Pathway","volume":"23","author":"Yodthong","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2021.107458_b0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/cr.2013.33","article-title":"Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis","volume":"23","author":"Choi","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.intimp.2021.107458_b0020","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1038\/s41598-018-25748-3","article-title":"Roles of Enhancer RNAs in RANKL-induced Osteoclast Differentiation Identified by Genome-wide Cap-analysis of Gene Expression using CRISPR\/Cas9","volume":"8","author":"Sakaguchi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2021.107458_b0025","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2005-08-3365","article-title":"Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro","volume":"107","author":"Yang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2021.107458_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133147","article-title":"Bone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation","volume":"20","author":"Yi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.intimp.2021.107458_b0035","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/jcmm.15003","article-title":"Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL-stimulated NFATc1 activity","volume":"24","author":"Liu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.intimp.2021.107458_b0040","doi-asserted-by":"crossref","first-page":"11190","DOI":"10.1038\/s41598-018-29257-1","article-title":"Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis","volume":"8","author":"Tzeng","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2021.107458_b0045","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1038\/s41598-018-23912-3","article-title":"Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-\u03baB pathway","volume":"8","author":"Chawalitpong","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.intimp.2021.107458_b0050","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3389\/fphar.2019.01587","article-title":"Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice","volume":"10","author":"Zhan","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.intimp.2021.107458_b0055","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0022034511402995","article-title":"Bisphosphonates induce senescence in normal human oral keratinocytes","volume":"90","author":"Kim","year":"2011","journal-title":"J Dent Res"},{"key":"10.1016\/j.intimp.2021.107458_b0060","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1038\/s41467-018-05974-z","article-title":"Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis","volume":"9","author":"Liang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.intimp.2021.107458_b0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18782","article-title":"Clec11a\/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton","volume":"5","author":"Yue","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2021.107458_b0070","first-page":"3032","article-title":"Effects of the extract of Ginkgo biloba on the differentiation of bone marrow mesenchymal stem cells in vitro","volume":"8","author":"Wu","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.intimp.2021.107458_b0075","article-title":"Recent Advances in the Development of CBP\/p300 Bromodomain Inhibitors","author":"Xiong","year":"2019","journal-title":"Current medicinal chemistry"},{"key":"10.1016\/j.intimp.2021.107458_b0080","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1242\/jcs.114.13.2363","article-title":"p300\/CBP proteins: HATs for transcriptional bridges and scaffolds","volume":"114","author":"Chan","year":"2001","journal-title":"Journal of cell science"},{"key":"10.1016\/j.intimp.2021.107458_b0085","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1007\/s00018-012-1254-4","article-title":"Transcriptional\/epigenetic regulator CBP\/p300 in tumorigenesis: structural and functional versatility in target recognition","volume":"70","author":"Wang","year":"2013","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"10.1016\/j.intimp.2021.107458_b0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pros.21257","article-title":"Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer","volume":"71","author":"Bouchal","year":"2011","journal-title":"The Prostate"},{"key":"10.1016\/j.intimp.2021.107458_b0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5","article-title":"p300 and CBP: partners for life and death","volume":"181","author":"Giordano","year":"1999","journal-title":"Journal of cellular physiology"},{"key":"10.1016\/j.intimp.2021.107458_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106014","article-title":"Flufenamic acid inhibits osteoclast formation and bone resorption and act against estrogen-dependent bone loss in mice","volume":"78","author":"Zhang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2021.107458_b0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jbmr.3342","article-title":"Monocyte-Specific Knockout of C\/ebp\u03b1 Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C\/ebp\u03b1 in Osteoclast Differentiation and Function","volume":"33","author":"Chen","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.intimp.2021.107458_b0110","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.intimp.2021.107458_b0115","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"},{"key":"10.1016\/j.intimp.2021.107458_b0120","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/nrdp.2016.69","volume":"2","author":"Eastell","year":"2016","journal-title":"Postmenopausal osteoporosis. Nature reviews Disease primers"},{"key":"10.1016\/j.intimp.2021.107458_b0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.intimp.2021.107458_b0130","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.intimp.2021.107458_b0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajhp\/zxy022","article-title":"Abaloparatide: A new pharmacological option for osteoporosis","volume":"76","author":"Sleeman","year":"2019","journal-title":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists"},{"key":"10.1016\/j.intimp.2021.107458_b0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1248\/yakushi.19-00125","article-title":"Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates","volume":"140","author":"Endo","year":"2020","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.intimp.2021.107458_b0145","first-page":"383","article-title":"Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review","volume":"27","author":"Nicolatou-Galitis","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.intimp.2021.107458_b0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw \u2014 Who gets it, and why?","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2021.107458_b0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107458_b0160","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.7150\/thno.30707","article-title":"p300\/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization","volume":"9","author":"Peng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2021.107458_b0165","first-page":"13832","volume":"234","author":"Liu","year":"2019","journal-title":"Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-\u03baB and MAPK signaling pathways."},{"key":"10.1016\/j.intimp.2021.107458_b0170","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbrc.2018.11.201","article-title":"Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-\u03baB and MAPK signaling pathways","volume":"508","author":"Xu","year":"2019","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.intimp.2021.107458_b0175","doi-asserted-by":"crossref","unstructured":"Kim J-w, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer research 2006; 66:8927-8930 %@ 0008-5472.","DOI":"10.1158\/0008-5472.CAN-06-1501"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:54:25Z","timestamp":1778619265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":35,"alternative-id":["S1567576921000941"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107458","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p300\/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107458"}}